ImmunityBio, Inc. ( IBRX) - Stock Earnings
IBRX Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 4, 2026, midnight | — / — | — | — / — | — |
IBRX Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -67.3 million USD | 32.1 million USD |
| 2025Q4 | -61.9 million USD | 38.3 million USD |
| 2026Q1 | -632.8 million USD | 44.2 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
IBRX Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -583.2 million USD | 622000 USD |
| 2024 | -413.6 million USD | 14.7 million USD |
| 2025 | -351.4 million USD | 113.3 million USD |
| 2026 Est. | — | — |
IBRX
Price: $7.68
Earnings Per Share: -0.85 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 1.2 million
Market Capitalization: 9.3 billion